Kids Face the Dangers of Hypertension
New guidelines from the National High Blood Pressure Education Program suggest hypertension screening for children starting atage 3, to continue throughout life. Dr. Bonita Falkner, professor of medicine and pediatrics at Thomas Jefferson University in Philadelphia,estimates that "One to three percent of the nation's children and adolescents may have hypertension or pre-hypertension andbe at risk of developing long-term, often serious and irreversible health problems as a consequence." Researchers found that theadult model for determining hypertension and prehypertension is not appropriate for children and adolescents because of the variedbody size, shape, height, weight, and other characteristics. The new guidelines would take these factors into account. They definehypertension in children as blood pressure above the 95th percentile and prehypertension between the 90th and 95th percentiles. Inadolescents, prehypertension is defined as a blood pressure higher than 120/80 mm Hg. Falkner adds, "Left ventricular hypertrophy(LVH) is the most prominent clinical evidence of target-organ damage caused by hypertension in children and adolescents. The presenceof LVH is an indication for physicians to initiate or intensify antihypertensive therapy." While parents do not need to make a specialdoctor's appointment to have blood pressure checked, they should make sure blood pressure screening is a part of their child'sannual physical exam?especially if there is a family history of hypertension.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025